BCDA
$2.20
Biocardia
($.03)
(1.35%)
BCDA
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  $0.00
Revenue:  N/A
Wednesday
Feb 9
4:30 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BCDA reports earnings?
Beat
Meet
Miss

Where is BCDA's stock price going from here?
Up
Flat
Down
Stock chart of BCDA
Analysts
Summary of analysts' recommendations for BCDA
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California.